{"pmid":32306036,"title":"Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients.","text":["Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients.","A novel coronavirus (COVID-19) pandemic threatens the world. Here, we first studied the dynamics profile of SARS-CoV-2 from 56 recovered COVID-19 patients. We found virus shedding was up to 6 weeks after onset of symptoms. Prolonged observation period is necessary for older patients.","Clin Infect Dis","Xiao, Ai Tang","Tong, Yi Xin","Zhang, Sheng","32306036"],"abstract":["A novel coronavirus (COVID-19) pandemic threatens the world. Here, we first studied the dynamics profile of SARS-CoV-2 from 56 recovered COVID-19 patients. We found virus shedding was up to 6 weeks after onset of symptoms. Prolonged observation period is necessary for older patients."],"journal":"Clin Infect Dis","authors":["Xiao, Ai Tang","Tong, Yi Xin","Zhang, Sheng"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32306036","week":"202017|Apr 20 - Apr 26","doi":"10.1093/cid/ciaa460","keywords":["covid-19","dynamics profile","sars-cov-2"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664641855665471488,"score":8.518259,"similar":[{"pmid":32270882,"title":"False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.","text":["False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.","A novel coronavirus (COVID-19) pandemic cause by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) threatens the world. We read with interest the recent report by Li et al. that included 610 patients with Coronavirus Disease 2019 (COVID-19). They reported a high false-negative rate of real-time reverse transcription polymerase chain reaction (RT-PCR) results for SARS-CoV-2 detection. In addition, recent report regarding SARS-CoV-2 \"turn positive\" in recovered cases with COVID-19 were published. Here, we studied the characteristics of nucleic acid conversion for SARS-CoV-2 from 70 COVID-19 patients. We found that 15 (21.4%) patients experienced a \"turn positive\" of nucleic acid detection by RT-PCR test for SARS-CoV-2 after two consecutive negative results, which may be related to the false negative of RT-PCR test and prolonged nucleic acid conversion This article is protected by copyright. All rights reserved.","J Med Virol","Xiao, Ai Tang","Tong, Yi Xin","Zhang, Sheng","32270882"],"abstract":["A novel coronavirus (COVID-19) pandemic cause by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) threatens the world. We read with interest the recent report by Li et al. that included 610 patients with Coronavirus Disease 2019 (COVID-19). They reported a high false-negative rate of real-time reverse transcription polymerase chain reaction (RT-PCR) results for SARS-CoV-2 detection. In addition, recent report regarding SARS-CoV-2 \"turn positive\" in recovered cases with COVID-19 were published. Here, we studied the characteristics of nucleic acid conversion for SARS-CoV-2 from 70 COVID-19 patients. We found that 15 (21.4%) patients experienced a \"turn positive\" of nucleic acid detection by RT-PCR test for SARS-CoV-2 after two consecutive negative results, which may be related to the false negative of RT-PCR test and prolonged nucleic acid conversion This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Xiao, Ai Tang","Tong, Yi Xin","Zhang, Sheng"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270882","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25855","keywords":["coronavirus < virus classification","sars coronavirus < virus classification","shedding < pathogenesis"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664637315576758273,"score":134.24524},{"pmid":32242348,"pmcid":"PMC7131901","title":"Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.","text":["Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19.","BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected pneumonia emerged in Wuhan, China in December 2019. In this retrospective multicenter study, we investigated the clinical course and outcomes of novel coronavirus disease 2019 (COVID-19) from early cases in Republic of Korea. METHODS: All of the cases confirmed by real time polymerase chain reaction were enrolled from the 1st to the 28th patient nationwide. Clinical data were collected and analyzed for changes in clinical severity including laboratory, radiological, and virologic dynamics during the progression of illness. RESULTS: The median age was 40 years (range, 20-73 years) and 15 (53.6%) patients were male. The most common symptoms were cough (28.6%) and sore throat (28.6%), followed by fever (25.0%). Diarrhea was not common (10.7%). Two patients had no symptoms. Initial chest X-ray (CXR) showed infiltration in 46.4% of the patients, but computed tomography scan confirmed pneumonia in 88.9% (16/18) of the patients. Six patients (21.4%) required supplemental oxygen therapy, but no one needed mechanical ventilation. Lymphopenia was more common in severe cases. Higher level of C-reactive protein and worsening of chest radiographic score was observed during the 5-7 day period after symptom onset. Viral shedding was high from day 1 of illness, especially from the upper respiratory tract (URT). CONCLUSION: The prodromal symptoms of COVID-19 were mild and most patients did not have limitations of daily activity. Viral shedding from URT was high from the prodromal phase. Radiological pneumonia was common from the early days of illness, but it was frequently not evident in simple CXR. These findings could be plausible explanations for the easy and rapid spread of SARS-CoV-2 in the community.","J Korean Med Sci","Kim, Eu Suk","Chin, Bum Sik","Kang, Chang Kyung","Kim, Nam Joong","Kang, Yu Min","Choi, Jae Phil","Oh, Dong Hyun","Kim, Jeong Han","Koh, Boram","Kim, Seong Eun","Yun, Na Ra","Lee, Jae Hoon","Kim, Jin Yong","Kim, Yeonjae","Bang, Ji Hwan","Song, Kyoung Ho","Kim, Hong Bin","Chung, Ki Hyun","Oh, Myoung Don","32242348"],"abstract":["BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected pneumonia emerged in Wuhan, China in December 2019. In this retrospective multicenter study, we investigated the clinical course and outcomes of novel coronavirus disease 2019 (COVID-19) from early cases in Republic of Korea. METHODS: All of the cases confirmed by real time polymerase chain reaction were enrolled from the 1st to the 28th patient nationwide. Clinical data were collected and analyzed for changes in clinical severity including laboratory, radiological, and virologic dynamics during the progression of illness. RESULTS: The median age was 40 years (range, 20-73 years) and 15 (53.6%) patients were male. The most common symptoms were cough (28.6%) and sore throat (28.6%), followed by fever (25.0%). Diarrhea was not common (10.7%). Two patients had no symptoms. Initial chest X-ray (CXR) showed infiltration in 46.4% of the patients, but computed tomography scan confirmed pneumonia in 88.9% (16/18) of the patients. Six patients (21.4%) required supplemental oxygen therapy, but no one needed mechanical ventilation. Lymphopenia was more common in severe cases. Higher level of C-reactive protein and worsening of chest radiographic score was observed during the 5-7 day period after symptom onset. Viral shedding was high from day 1 of illness, especially from the upper respiratory tract (URT). CONCLUSION: The prodromal symptoms of COVID-19 were mild and most patients did not have limitations of daily activity. Viral shedding from URT was high from the prodromal phase. Radiological pneumonia was common from the early days of illness, but it was frequently not evident in simple CXR. These findings could be plausible explanations for the easy and rapid spread of SARS-CoV-2 in the community."],"journal":"J Korean Med Sci","authors":["Kim, Eu Suk","Chin, Bum Sik","Kang, Chang Kyung","Kim, Nam Joong","Kang, Yu Min","Choi, Jae Phil","Oh, Dong Hyun","Kim, Jeong Han","Koh, Boram","Kim, Seong Eun","Yun, Na Ra","Lee, Jae Hoon","Kim, Jin Yong","Kim, Yeonjae","Bang, Ji Hwan","Song, Kyoung Ho","Kim, Hong Bin","Chung, Ki Hyun","Oh, Myoung Don"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32242348","week":"202014|Mar 30 - Apr 05","doi":"10.3346/jkms.2020.35.e142","keywords":["covid-19","cohort study","prognosis","republic of korea","sars-cov-2","viral pneumonia"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China","South Korea"],"countries":["Korea, Republic of","China"],"countries_codes":["KOR|Korea, Republic of","CHN|China"],"_version_":1664638249326346240,"score":125.3121},{"pmid":32297851,"title":"Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen, China.","text":["Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen, China.","Among all 209 discharged coronavirus 2019 patients in Shenzhen China between January 23 and February 21, 2020, there are 9 (4.3%) patients showed RT-PCR positive in throat swabs, 13 (6.2%) patients showed RT-PCR positive in anal swabs, and 22 (10.5%) positive in either type. The time between discharge and positive RT-PCR tests is 4.7 days on average. These numbers shed light on the viral dynamics of COVID-19.","Infect Control Hosp Epidemiol","Tang, Xiujuan","Zhao, Shi","He, Daihai","Yang, Lin","Wang, Maggie H","Li, Yuan","Mei, Shujiang","Zou, Xuan","32297851"],"abstract":["Among all 209 discharged coronavirus 2019 patients in Shenzhen China between January 23 and February 21, 2020, there are 9 (4.3%) patients showed RT-PCR positive in throat swabs, 13 (6.2%) patients showed RT-PCR positive in anal swabs, and 22 (10.5%) positive in either type. The time between discharge and positive RT-PCR tests is 4.7 days on average. These numbers shed light on the viral dynamics of COVID-19."],"journal":"Infect Control Hosp Epidemiol","authors":["Tang, Xiujuan","Zhao, Shi","He, Daihai","Yang, Lin","Wang, Maggie H","Li, Yuan","Mei, Shujiang","Zou, Xuan"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297851","week":"202016|Apr 13 - Apr 19","doi":"10.1017/ice.2020.134","keywords":["covid-19","rt-pcr","age","coronavirus disease 2019","diarrhea","discharge"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Shenzhen","China","Shenzhen","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664641388315148289,"score":116.078316},{"pmid":32335171,"title":"Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.","text":["Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.","BACKGROUND: Since its discovery, SARS-CoV-2 has been spread throughout China before becoming a global pandemic. In Beijing, family clusters are the main mode of human-human transmission accounting for 57.6% of the total confirmed cases. METHOD: We present the epidemiological and clinical features of the clusters of three large and one small families. RESULT: Our results revealed that SARS-CoV-2 is transmitted quickly through contact with index case, and a total of 22/24 infections were observed. Among those infected, 20/22 had mild symptoms and only two had moderate to severe clinical manifestations. Children in the families generally showed milder symptoms. The incubation period varied from 2 to 13 days, and the shedding of virus from the upper respiratory tract lasted from 5 to over 30 days. A prolonged period of virus shedding (>30 days) in upper respiratory tract was observed in 6/24 cases. CONCLUSION: SARS-CoV-2 is transmitted quickly in the form of family clusters. While the infection rate is high within the cluster, the disease manifestations, latent period, and virus shedding period varied greatly. We therefore recommend rigorously testing contacts even during the no-symptom phase and consider whether viral shedding has ceased before stopping isolation measures for an individual.","J Infect","Song, Rui","Han, Bing","Song, Meihua","Wang, Lin","Conlon, Christopher P","Dong, Tao","Tian, Di","Zhang, Wei","Chen, Zhihai","Zhang, Fujie","Shi, Mang","Li, Xingwang","32335171"],"abstract":["BACKGROUND: Since its discovery, SARS-CoV-2 has been spread throughout China before becoming a global pandemic. In Beijing, family clusters are the main mode of human-human transmission accounting for 57.6% of the total confirmed cases. METHOD: We present the epidemiological and clinical features of the clusters of three large and one small families. RESULT: Our results revealed that SARS-CoV-2 is transmitted quickly through contact with index case, and a total of 22/24 infections were observed. Among those infected, 20/22 had mild symptoms and only two had moderate to severe clinical manifestations. Children in the families generally showed milder symptoms. The incubation period varied from 2 to 13 days, and the shedding of virus from the upper respiratory tract lasted from 5 to over 30 days. A prolonged period of virus shedding (>30 days) in upper respiratory tract was observed in 6/24 cases. CONCLUSION: SARS-CoV-2 is transmitted quickly in the form of family clusters. While the infection rate is high within the cluster, the disease manifestations, latent period, and virus shedding period varied greatly. We therefore recommend rigorously testing contacts even during the no-symptom phase and consider whether viral shedding has ceased before stopping isolation measures for an individual."],"journal":"J Infect","authors":["Song, Rui","Han, Bing","Song, Meihua","Wang, Lin","Conlon, Christopher P","Dong, Tao","Tian, Di","Zhang, Wei","Chen, Zhihai","Zhang, Fujie","Shi, Mang","Li, Xingwang"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335171","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jinf.2020.04.018","keywords":["covid-19","coronavirus disease-19","epidemiological features","family clusters","sars-cov-2"],"source":"PubMed","topics":["Diagnosis","Transmission"],"weight":1,"locations":["China","Beijing","Beijing","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1665172301982728193,"score":113.28494},{"pmid":32306864,"title":"Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients.","text":["Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients.","Effective strategy to mitigate the ongoing pandemic of 2019 novel coronavirus (COVID-19) require a comprehensive understanding of humoral responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the emerging virus causing COVID-19. The dynamic profile of viral replication and shedding along with viral antigen specific antibody responses among COVID-19 patients started to be reported but there is no consensus on their patterns. Here, we conducted a serial investigation on 21 individuals infected with SARS-CoV-2 in two medical centers from Jiangsu Province, including 11 non-severe COVID-19 patients, and 5 severe COVID-19 patients and 5 asymptomatic carriers based on nucleic acid test and clinical symptoms. The longitudinal swab samples and sera were collected from these people for viral RNA testing and antibody responses, respectively. Our data revealed different pattern of seroconversion among these groups. All 11 non-severe COVID-19 patients and 5 severe COVID-19 patients were seroconverted during hospitalization or follow-up period, suggesting that serological testing is a complementary assay to nucleic acid test for those symptomatic COVID-19 patients. Of note, immediate antibody responses were identified among severe cases, compared to non-severe cases. On the other hand, only one were seroconverted for asymptomatic carriers. The SARS-CoV-2 specific antibody responses were well-maintained during the observation period. Such information is of immediate relevance and would assist COVID-19 clinical diagnosis, prognosis and vaccine design.","Emerg Microbes Infect","Yongchen, Zhang","Shen, Han","Wang, Xinning","Shi, Xudong","Li, Yang","Yan, Jiawei","Chen, Yuxin","Gu, Bing","32306864"],"abstract":["Effective strategy to mitigate the ongoing pandemic of 2019 novel coronavirus (COVID-19) require a comprehensive understanding of humoral responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the emerging virus causing COVID-19. The dynamic profile of viral replication and shedding along with viral antigen specific antibody responses among COVID-19 patients started to be reported but there is no consensus on their patterns. Here, we conducted a serial investigation on 21 individuals infected with SARS-CoV-2 in two medical centers from Jiangsu Province, including 11 non-severe COVID-19 patients, and 5 severe COVID-19 patients and 5 asymptomatic carriers based on nucleic acid test and clinical symptoms. The longitudinal swab samples and sera were collected from these people for viral RNA testing and antibody responses, respectively. Our data revealed different pattern of seroconversion among these groups. All 11 non-severe COVID-19 patients and 5 severe COVID-19 patients were seroconverted during hospitalization or follow-up period, suggesting that serological testing is a complementary assay to nucleic acid test for those symptomatic COVID-19 patients. Of note, immediate antibody responses were identified among severe cases, compared to non-severe cases. On the other hand, only one were seroconverted for asymptomatic carriers. The SARS-CoV-2 specific antibody responses were well-maintained during the observation period. Such information is of immediate relevance and would assist COVID-19 clinical diagnosis, prognosis and vaccine design."],"journal":"Emerg Microbes Infect","authors":["Yongchen, Zhang","Shen, Han","Wang, Xinning","Shi, Xudong","Li, Yang","Yan, Jiawei","Chen, Yuxin","Gu, Bing"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32306864","week":"202017|Apr 20 - Apr 26","doi":"10.1080/22221751.2020.1756699","keywords":["covid-19","sars-cov-2","antibody responses","serology testing","viral nucleic acid"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["Jiangsu","sera"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664632501344141313,"score":110.507454}]}